These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27241174)

  • 41. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.
    Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M
    Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclodextrin Reduces Cholesterol Crystal-Induced Inflammation by Modulating Complement Activation.
    Bakke SS; Aune MH; Niyonzima N; Pilely K; Ryan L; Skjelland M; Garred P; Aukrust P; Halvorsen B; Latz E; Damås JK; Mollnes TE; Espevik T
    J Immunol; 2017 Oct; 199(8):2910-2920. PubMed ID: 28855312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin inhibits inflammation and promotes atherosclerotic plaque stability via PI3K-Akt pathway activation.
    Yan H; Ma Y; Li Y; Zheng X; Lv P; Zhang Y; Li J; Ma M; Zhang L; Li C; Zhang R; Gao F; Wang H; Tao L
    Immunol Lett; 2016 Feb; 170():7-14. PubMed ID: 26681144
    [TBL] [Abstract][Full Text] [Related]  

  • 44. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drugs targeting atherosclerosis: current and emerging approaches.
    Manolopoulos VG; Tavridou A
    Curr Pharm Des; 2009; 15(27):3091-3. PubMed ID: 19754383
    [No Abstract]   [Full Text] [Related]  

  • 46. Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability.
    Nidorf SM; Fiolet A; Abela GS
    J Clin Lipidol; 2020; 14(5):619-630. PubMed ID: 32792218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Poly-β-cyclodextrin Supramolecular Nanoassembly with a pH-Sensitive Switch Removing Lysosomal Cholesterol Crystals for Antiatherosclerosis.
    Zhang Y; Gong F; Wu Y; Hou S; Xue L; Su Z; Zhang C
    Nano Lett; 2021 Nov; 21(22):9736-9745. PubMed ID: 34748340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclodextrins: Potential therapeutics against atherosclerosis.
    Mahjoubin-Tehran M; Kovanen PT; Xu S; Jamialahmadi T; Sahebkar A
    Pharmacol Ther; 2020 Oct; 214():107620. PubMed ID: 32599008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.
    Kusters PJH; Lutgens E; Seijkens TTP
    Cardiovasc Res; 2018 Mar; 114(3):368-377. PubMed ID: 29309533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Erythrocyte membrane cholesterol and lipid core growth in a rabbit model of atherosclerosis: modulatory effects of rosuvastatin.
    Tziakas D; Chalikias G; Kapelouzou A; Tentes I; Schäfer K; Karayannakos P; Kostakis A; Boudoulas H; Konstantinides S
    Int J Cardiol; 2013 Dec; 170(2):173-81. PubMed ID: 24215985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting Nanoplatform for Atherosclerosis Inhibition and Degradation via a Dual-Track Reverse Cholesterol Transport Strategy.
    Chen Z; Zhu Q; Li D; Lv Q; Fu G; Ma B; Zhang W
    Small; 2024 Feb; 20(7):e2306457. PubMed ID: 37803917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis.
    Palekar RU; Jallouk AP; Myerson JW; Pan H; Wickline SA
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):446-55. PubMed ID: 26769047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation.
    Abela GS
    J Clin Lipidol; 2010; 4(3):156-64. PubMed ID: 21122648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets.
    Oesterle A; Bowman MA
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2496-507. PubMed ID: 26515415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Research Progress on the Relationship between Atherosclerosis and Inflammation.
    Zhu Y; Xian X; Wang Z; Bi Y; Chen Q; Han X; Tang D; Chen R
    Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30142970
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis.
    Freigang S; Ampenberger F; Spohn G; Heer S; Shamshiev AT; Kisielow J; Hersberger M; Yamamoto M; Bachmann MF; Kopf M
    Eur J Immunol; 2011 Jul; 41(7):2040-51. PubMed ID: 21484785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of Low Molecular Weight Substances and Related Processes Influencing Cellular Cholesterol Efflux.
    Litvinov DY; Savushkin EV; Dergunov AD
    Pharmaceut Med; 2019 Dec; 33(6):465-498. PubMed ID: 31933239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin.
    Qi C; Deng L; Li D; Wu W; Gong L; Li Y; Zhang Q; Zhang T; Zhang C; Zhang Y
    PLoS One; 2015; 10(5):e0125677. PubMed ID: 25973795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simvastatin reduces expression and activity of lipoprotein-associated phospholipase A(2) in the aorta of hypercholesterolaemic atherosclerotic rabbits.
    Qiao Z; Ren J; Chen H
    J Int Med Res; 2009; 37(4):1029-37. PubMed ID: 19761685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.